SIRPA and neoplasm: For example, genetic engineering has been used tomodify HEK293T cells to generate exosomes that overexpress SIRPα to act as a cancertherapeutic by disrupting CD47-SIRPα interactions between tumor cells and macrophages toattenuate the ability of tumor cells to resist phagocytosis.55